Fund profile / Australia

Brandon Capital Australasia Fund 6

Geography: Australia
Stage: Growth
Fund size: A$439M+
Focus: Biotech, Digital Health and MedTech
Signals: Published

N°01 / About

About Brandon Capital Australasia Fund 6

Life Sciences, HealthTech, MedTech focused fund

N°02 / Thesis

Investment Focus

Location / RegionAustralia

Funding StageGrowth

Industry Focus

Biotech

Digital Health

MedTech

Investor Signals Profile

active

Sweet Spot

ANZ biotech/medtech with clinical proof, US scaling ready

medtech

oncology

life sciences

Australia/ANZ

radioligand therapies

clinical-stage biotech

US scaling model

inflammasome therapeutics

neurotology

medical devices

RDTI-eligible R&D

sleep biology

neurodegenerative disease

Bullish Signals

Portfolio co presenting at RACS 2026external

Active medtech portfolio engagementexternal

OncoRes CMO keynote — RACS Perthlinkedin

Portfolio active in breast cancer trialslinkedin

Brandon Capital amplifying OncoRes RACS sessionslinkedin

Portfolio CMO: dual RACS keynote slotslinkedin

Portfolio CMO: gendered lens surgical carelinkedin

AdvanCell raised US$315m oncology financinglinkedin

Myricx acquired by Novartis post-Brandonlinkedin

Top-tier US/UK/AU syndicate backing portfoliolinkedin

BioCatalyst 6 fund deploying into late-stagelinkedin

6 AU health innovators awarded $13.5m via CUREator+linkedin

CUREator+ milestone-based funding + commercialisation supportlinkedin

MRFF partnership expanding AU research translationlinkedin

Aleris, Frontier Inflammasome, Luma, Navier, Neurotologix, WeGuide fundedlinkedin

Brandon Capital advising on RDTI tax incentive optimizationlinkedin

AstronauTx featured BioCentury sleep-neuro investment articlelinkedin

AstronauTx applying sleep biology to neurodegenerationlinkedin

Contrarian Signals

Narrow sector focus — healthcare onlyexternal

Founder Do's

Build in medtech or life sciences

Show clinical validation or trials

Target ANZ or Asia-Pacific market

Engage clinical leaders / KOLs

Link to translational research

Plan US expansion post-proof

Syndicate with top-tier US/UK investors

Apply for CUREator+ milestone funding

Leverage Brandon BioCatalyst ecosystem support

Optimize RDTI / IBCC tax positioning

Explore sleep science therapeutic angles

Founder Don'ts

Avoid non-healthcare sectors

Don't skip clinical evidence

No consumer or SaaS pitches

38 signals on Brandon Capital Australasia Fund 6

18 bullish · 1 contrarian · 11 pitch do's · 3 don'ts · 5 GP profiles, each with its source. From €9/month, cancel anytime.

See a signal free View Plans Browse all Signal Profiles →

Facts

Fund Overview

Fund SizeA$439M+

Saves0

Website

People

Key People

Dr. Chris Nave, Chris Smith, Melissa McBurnie

Jonathan TobinPartner

Chris NavePartner

Michael BettessPartner

Prashanth RajanPartner

Amanda VrseljaProgram Head

N°04 / See also

Related Funds

Galileo Ventures Fund II

Fund size$15M

Location: Australia
Stage: Pre Seed
Focus
Manager: James Alexander, Hugh Stephens

Pre Seed

Glitch Capital (Founders Fund)

Fund sizeA$50M

Location: Australia
Stage: Pre Seed
Focus: Saas
Manager: Ryan Fitzpatrick, Rob Hillpot

Pre Seed

Saas

Airtree Ventures

Fund size$650M

Location: Australia
Stage: Seed
Focus: Saas, Ai Ml
Manager: Kelland Reilly, Helen Norton, Jackie Vullinghs

Seed

Saas

Ai Ml